129 related articles for article (PubMed ID: 3000210)
1. Significance of enzyme markers as a part of multiple marker analysis in leukemia research.
Drexler HG; Gaedicke G
Am J Pediatr Hematol Oncol; 1985; 7(3):283-9. PubMed ID: 3000210
[TBL] [Abstract][Full Text] [Related]
2. Biochemical enzyme analysis in acute leukaemia.
Drexler HG; Gaedicke G; Minowada J
J Clin Pathol; 1985 Feb; 38(2):117-27. PubMed ID: 2981904
[TBL] [Abstract][Full Text] [Related]
3. Enzyme markers in acute leukemias: advances during the last decade.
Drexler HG; Gaedicke G; Minowada J
J Natl Cancer Inst; 1984 Jun; 72(6):1283-98. PubMed ID: 6328091
[TBL] [Abstract][Full Text] [Related]
4. Enzyme alterations in leukemic cells.
Dunn NL; Maurer HM
Am J Hematol; 1982 Dec; 13(4):343-51. PubMed ID: 6297298
[TBL] [Abstract][Full Text] [Related]
5. Cell surface markers in leukemia: biological and clinical correlations.
Thiel E
Crit Rev Oncol Hematol; 1985; 2(3):209-60. PubMed ID: 3013441
[TBL] [Abstract][Full Text] [Related]
6. [Adenosine deaminase, purine nucleoside phosphorylase and ecto-5'-nucleotidase--markers of acute leukemia variants].
Filanovskaia LI; Togo AV; Tsveĭbakh AS; Blinov MN; Alekseev NA
Vopr Med Khim; 1987; 33(4):16-21. PubMed ID: 2821693
[TBL] [Abstract][Full Text] [Related]
7. [Isoenzymes of blast cells in malignant hemopathies: present state and prospectives].
Vigneron C; Marchand-Arvier M
Ann Biol Clin (Paris); 1985; 43(2):117-25. PubMed ID: 3000227
[TBL] [Abstract][Full Text] [Related]
8. Biochemical markers as indicators of prognosis in acute nonlymphocytic leukemia (ANLL).
Skoog L; Nordenskjöld B; Ost A; Andersson B; Hast R; Giannoulis N; Reitzenstein P
Adv Enzyme Regul; 1980; 19():287-93. PubMed ID: 6278867
[No Abstract] [Full Text] [Related]
9. Adenosine deaminase, purine nucleoside phosphorylase and 5'-nucleotidase activities in infectious mononucleosis.
Mejer J; Nygaard P; Cohn J; Gadeberg O; Faber V
Adv Exp Med Biol; 1984; 165 Pt A():249-52. PubMed ID: 6326481
[No Abstract] [Full Text] [Related]
10. Enzyme patterns in normal lymphocyte subpopulations, lymphoid leukaemias and immunodeficiency syndromes.
Hoffbrand AV; Ma DD; Webster AD
Clin Haematol; 1982 Oct; 11(3):719-41. PubMed ID: 6293744
[No Abstract] [Full Text] [Related]
11. Purine pathway enzyme abnormalities in acute lymphoblastic leukemia.
Poplack DG; Blatt J; Reaman G
Cancer Res; 1981 Nov; 41(11 Pt 2):4821-23. PubMed ID: 6271395
[TBL] [Abstract][Full Text] [Related]
12. [Biological and immunological markers in acute leukaemia (author's transl)].
López Borrasca A; González M; Hernández F; Ledesma M; Corrales A; San Miguel J
Sangre (Barc); 1981; 26(5B):756-82. PubMed ID: 6275558
[No Abstract] [Full Text] [Related]
13. Purine degradative enzymes in circulating malignant cells of patients with chronic B cell neoplasia.
Ho AD; Knauf W; Ganeshaguru K; Hunstein W; Hoffbrand AV
Hematol Oncol; 1987; 5(1):9-17. PubMed ID: 3032762
[TBL] [Abstract][Full Text] [Related]
14. Purine metabolism in leukemia.
Agarwal RP; Bell R; Lillquist A; McCaffrey R
Ann N Y Acad Sci; 1985; 451():160-8. PubMed ID: 3000253
[No Abstract] [Full Text] [Related]
15. Comparison of purine degradative enzymes and terminal deoxynucleotidyl transferase in T cell leukaemias and in normal thymic and post-thymic T cells.
Ma DD; Massaia M; Sylwestrowicz TA; Price G; Hoffbrand AV
Br J Haematol; 1983 Jul; 54(3):451-7. PubMed ID: 6305393
[TBL] [Abstract][Full Text] [Related]
16. Enzymes of purine metabolism in B-chronic lymphocytic leukemia.
Vertongen F; Cauchie C; Courtois P; Fondu P; Mandelbaum IM
Am J Hematol; 1984 Jul; 17(1):61-70. PubMed ID: 6331155
[TBL] [Abstract][Full Text] [Related]
17. Purine metabolizing enzyme activities in lymphoblastic leukemia.
van Laarhoven JP; Spierenburg GT; de Gast GC; Schouten TJ; De Bruyn CH
Adv Exp Med Biol; 1984; 165 Pt B():233-40. PubMed ID: 6326501
[No Abstract] [Full Text] [Related]
18. Leukemic cell differentiation in childhood leukemias. Analysis by enzyme markers.
Gaedicke G; Drexler HG
Eur J Pediatr; 1984 Aug; 142(3):157-64. PubMed ID: 6236088
[TBL] [Abstract][Full Text] [Related]
19. Purine degradative enzymes and immunological phenotypes in chronic B-lymphocytic leukaemia: indications that leukaemic immunocytoma is a separate entity.
Ho AD; Dörken B; Ma DD; Pezzutto A; Hunstein W; Hoffbrand AV
Br J Haematol; 1986 Mar; 62(3):545-55. PubMed ID: 3006740
[TBL] [Abstract][Full Text] [Related]
20. [Degradation of purines in leukocytes in acute nonlymphoblastic leukemias].
Filanovskaia LI; Blinov MN; Togo AV; Klubovskaia NI; Burmistrova EV
Vopr Med Khim; 1988; 34(6):71-6. PubMed ID: 2853490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
